Could hydrogen gas help protect newborn brains? early trial launches

NCT ID NCT07411911

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests whether adding hydrogen gas to standard cooling therapy is safe and feasible for newborns who suffered brain injury from lack of oxygen at birth (HIE). About 54 infants will be randomly assigned to receive either standard cooling alone or cooling plus 2% hydrogen gas through their breathing support for 72 hours. The main goals are to check for side effects and see if the hydrogen can be given reliably, not yet to measure long-term benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hydrogen gas (2% mixed with breathing gases)
What this could lead to
If safe and feasible, this could pave the way for a larger trial to see if hydrogen gas helps reduce brain damage in newborns with HIE.
What could go wrong
This is a very early Phase 1 safety trial with only 54 infants. It is not designed to prove whether hydrogen actually improves outcomes, and the treatment is added to standard cooling, not replacing it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.